About Golodirsen API

High-Purity Golodirsen API for Duchenne Muscular Dystrophy Treatment

Golodirsen API is a pharmaceutical-grade antisense phosphorodiamidate morpholino oligomer (PMO) developed for the treatment of Duchenne Muscular Dystrophy (DMD) in patients with mutations amenable to exon 53 skipping. It binds specifically to exon 53 of dystrophin pre-mRNA, promoting exon skipping during RNA processing and enabling the production of a shorter but functional dystrophin protein.

This targeted genetic approach helps slow disease progression and preserve muscle function in eligible DMD patients. Golodirsen represents an important advancement in precision medicine and rare disease therapy.

Swapnroop Drugs and Pharmaceuticals manufactures premium-quality Golodirsen API under stringent WHO-GMP manufacturing standards. Every batch undergoes comprehensive testing for purity, identity, oligonucleotide integrity, sterility, and stability. Complete regulatory documentation, including Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), and technical specifications, is available.

Key Features

High-purity pharmaceutical-grade oligonucleotide API
Antisense phosphorodiamidate morpholino oligomer (PMO)
Exon 53 skipping technology
High biological activity
Excellent stability profile
WHO-GMP compliant manufacturing
Low impurity profile
Sterile manufacturing process
Complete CoA & MSDS
Worldwide bulk supply

Applications

Duchenne Muscular Dystrophy (DMD)
Exon 53 skipping therapy
Rare genetic disease treatment
Injectable formulations
Neuromuscular disease therapy
Biopharmaceutical manufacturing
Clinical research
Precision medicine development

Why Choose Swapnroop Pharma

WHO-GMP Certified Manufacturing Facility
Advanced Oligonucleotide Manufacturing Technology
High-Purity Pharmaceutical APIs
Comprehensive Quality Control
Complete Regulatory Documentation
Competitive Bulk Pricing
Reliable Worldwide Export
Technical & Regulatory Support
Consistent Batch Quality
Customized Packaging Solutions

Packaging & Supply

Golodirsen API is supplied in validated sterile pharmaceutical packaging suitable for commercial manufacturing and clinical applications.

Available Packaging Options:

Sterile Glass Vials
Clinical Trial Packaging
Commercial Bulk Packaging
Custom Packaging Available

Each shipment includes:

Certificate of Analysis (CoA)
Material Safety Data Sheet (MSDS)
Product Specification Sheet
Batch Manufacturing Record
Stability Data
Product Label
Technical Documentation

Frequently Asked Questions (FAQs)

1. What is Golodirsen API used for?

Golodirsen API is used for the treatment of Duchenne Muscular Dystrophy (DMD) in patients with mutations amenable to exon 53 skipping.

2. How does Golodirsen work?

Golodirsen binds to dystrophin pre-mRNA and promotes exon 53 skipping, allowing production of a shortened but functional dystrophin protein.

3. What therapeutic class does Golodirsen belong to?

Golodirsen belongs to the Antisense Oligonucleotide (PMO) class of genetic therapies.

4. Is regulatory documentation available?

Yes. We provide Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), technical specifications, and complete regulatory documentation.

5. Is bulk commercial supply available?

Yes. We offer commercial bulk quantities with reliable worldwide export support.

Get Bulk Quote via WhatsApp